Category Archives: Pr Newswire

Provectus Biopharmaceuticals Announces Investor Webinar for 2024 Annual Meeting of Stockholders

KNOXVILLE, Tenn., June 13, 2024 (GLOBE NEWSWIRE) — Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) announced today that its 2024 annual stockholder meeting (the “2024 Annual Meeting”), including meeting activities and a company update, will be accessible by Zoom Webinar. The meeting will be held on Thursday, June 20, 2024 at the Hilton […]

Araris Biotech AG Appoints Dr. Ulf Grawunder to Scientific Advisory Board

AU ZH, Switzerland, June 13, 2024 (GLOBE NEWSWIRE) — Araris Biotech AG (“Araris” or “the Company”), a company pioneering a proprietary antibody-drug conjugate (ADC)- technology, today announced the appointment of Ulf Grawunder, Ph.D. to its scientific advisory board. Dr. Grawunder will support the company as it continues to expand its pipeline of innovative ADC candidates, […]

Conduit Pharmaceuticals to Join Russell 3000® Index

SAN DIEGO and LONDON, June 13, 2024 (GLOBE NEWSWIRE) — Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (the “Company” or “Conduit”), today announced the Company is set to join the broad-market Russell 3000® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective at the open of US equity markets on Monday, July 1, […]

Omdia: OLED materials market will resume the growth to reach over $2billion in 2024

LONDON, June 13, 2024 /PRNewswire/ — According to Omdia’s latest report, the global market for OLED materials is poised for a rebound after experiencing a deficit in recent years. The findings from Omdia’s latest ‘OLED Materials Market Tracker – 2Q24C‘ released in June, indicate a shift in trajectory. While OLED materials had been on a […]

Concordia International School Shanghai Named in Top 10 Shortlist for World’s Best School Prizes

Concordia Shanghai named in Top 10 shortlist for World’s Best School Prize for Supporting Healthy Lives SHANGHAI, June 13, 2024 /PRNewswire/ — An international school in China has been named in the Top 10 shortlists for the World’s Best School Prizes 2024. The five World’s Best School Prizes, founded by T4 Education in collaboration with […]

Venture Global Announces Landmark Energy Security Agreement with DTEK of Ukraine

ARLINGTON, Va., June 13, 2024 /PRNewswire/ — Today, Venture Global and D. TRADING (commercial arm of DTEK Group) announced the execution of a comprehensive Heads of Agreement (HOA) for the supply of U.S. liquefied natural gas (LNG) to Ukraine and Eastern Europe. The HOA provides that DTEK’s subsidiary, D. TRADING, will purchase cargoes from Venture […]

D.R. Horton Offers Canadian Solar PV Panels and Residential Batteries to Power California Communities

GUELPH, ON, June 13, 2024 /PRNewswire/ — Canadian Solar Inc. (the “Company” or “Canadian Solar”) (NASDAQ: CSIQ) announced today that it has entered into an agreement with U.S. homebuilder D.R. Horton to offer its solar and energy storage products across communities in California. Under the agreement, Canadian Solar will provide a total home energy battery back-up […]

Sirnaomics Demonstrates Strong Antitumor Activity of Its Novel Oligonucleotide-ChemoDrug Conjugate in Journal of Oncology Research and Therapy

HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 13, 2024 /PRNewswire/ — Sirnaomics Ltd. (the “Company”; together with its subsidiaries, “Sirnaomics” or the “Group“; stock code: 2257), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced that the Group has published a major advancement of its novel Oligonucleotide-Chemodrug Conjugate (ODC) agent. The ODC […]

Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar

MELBOURNE, Australia and SAN FRANCISCO, June 12, 2024 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief Executive Officer will present a company overview at the MST Access ‘Hidden Gems in Life […]

Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, CA and TAICANG, China, June 12, 2024 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect or the Company), a U.S.-headquartered, global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research, announced today that the Board of […]